L. Z. Cooper

734 total citations
18 papers, 488 citations indexed

About

L. Z. Cooper is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, L. Z. Cooper has authored 18 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in L. Z. Cooper's work include Virology and Viral Diseases (10 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Respiratory viral infections research (4 papers). L. Z. Cooper is often cited by papers focused on Virology and Viral Diseases (10 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Respiratory viral infections research (4 papers). L. Z. Cooper collaborates with scholars based in United States, United Kingdom and Guatemala. L. Z. Cooper's co-authors include S Krugman, Elena Buimovici‐Klein, Barbara Fedun, P Rubinstein, Fredda Ginsberg‐Fellner, Mary E. Walker, Jerry S. Wolinsky, Soroku Yagihashi, Robert C. McEvoy and Sonia Román and has published in prestigious journals such as Diabetes, American Journal of Public Health and Annals of the New York Academy of Sciences.

In The Last Decade

L. Z. Cooper

18 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Z. Cooper United States	12	235	192	110	106	95	18	488
P Leinikki Finland	10	123 0.5×	182 0.9×	77 0.7×	89 0.8×	110 1.2×	26	407
JillM. Forrest Australia	6	121 0.5×	305 1.6×	166 1.5×	102 1.0×	65 0.7×	8	469
J M T Willoughby United Kingdom	12	250 1.1×	269 1.4×	164 1.5×	104 1.0×	75 0.8×	20	651
Valérie Lecouturier France	12	266 1.1×	263 1.4×	117 1.1×	128 1.2×	282 3.0×	16	667
Chengjin Huang China	11	173 0.7×	86 0.4×	54 0.5×	40 0.4×	61 0.6×	18	415
Laurence Serradell France	11	317 1.3×	73 0.4×	157 1.4×	90 0.8×	21 0.2×	20	509
Martha Cannon United Kingdom	13	93 0.4×	135 0.7×	63 0.6×	50 0.5×	48 0.5×	16	561
Jorge Murillo Spain	12	165 0.7×	90 0.5×	103 0.9×	24 0.2×	72 0.8×	28	477
Howard D. Strickler United States	13	259 1.1×	56 0.3×	94 0.9×	67 0.6×	75 0.8×	23	653
Z T Handzel Israel	14	172 0.7×	33 0.2×	31 0.3×	186 1.8×	62 0.7×	31	498

Countries citing papers authored by L. Z. Cooper

Since Specialization

Citations

This map shows the geographic impact of L. Z. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Z. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Z. Cooper more than expected).

Fields of papers citing papers by L. Z. Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Z. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Z. Cooper. The network helps show where L. Z. Cooper may publish in the future.

Co-authorship network of co-authors of L. Z. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of L. Z. Cooper. A scholar is included among the top collaborators of L. Z. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Z. Cooper. L. Z. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Cooper, L. Z., et al.. (2024). Dopamine Agonists as a Novel “Cure” for Autoimmune Diabetes. JCEM Case Reports. 2(2). luad176–luad176. 2 indexed citations

Buimovici‐Klein, Elena, et al.. (1992). Modulation of alpha interferon levels by AZT treatment in HIV-seropositive patients.. PubMed. 6(1-2). 31–9. 4 indexed citations

Plotkin, Stanley A., L. Z. Cooper, Norman Fost, et al.. (1992). Perinatal human immunodeficiency virus (HIV) testing. 89(2). 791–794. 15 indexed citations

Buimovici‐Klein, Elena, Kenneth R. Ong, M. Lange, et al.. (1986). REVERSE TRANSCRIPTASE ACTIVITY (RTA) IN LYMPHOCYTE CULTURES OF AIDS PATIENTS TREATED WITH HPA-23. PubMed. 2(4). 279–283. 8 indexed citations

Lange, Michael, Elena Buimovici‐Klein, Hardy Kornfeld, et al.. (1984). PROSPECTIVE OBSERVATIONS OF VIRAL AND IMMUNOLOGIC ABNORMALITIES IN HOMOSEXUAL MALES. Annals of the New York Academy of Sciences. 437(1). 350–363. 4 indexed citations

Ginsberg‐Fellner, Fredda, M.E. Witt, Soroku Yagihashi, et al.. (1984). Congenital rubella syndrome as a model for Type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia. 27(S1). 87–89. 97 indexed citations

Rubinstein, Pablo, et al.. (1982). The HLA system in congenital rubella patients with and without diabetes. Diabetes. 31(12). 1088–1091. 38 indexed citations

Rubinstein, Pablo, et al.. (1982). The HLA system in congenital rubella (CR) patients with and without diabetes. Human Immunology. 5(2). 168–168. 4 indexed citations

Rubinstein, P, et al.. (1982). The HLA System in Congenital Rubella Patients With and Without Diabetes. Diabetes. 31(12). 1088–1091. 73 indexed citations

10.

Coyle, Patricia K., et al.. (1982). Rubella-specific immune complexes after congenital infection and vaccination. Infection and Immunity. 36(2). 498–503. 30 indexed citations

11.

Buimovici‐Klein, Elena, et al.. (1980). Low level rubella immunity detected by ELISA and specific lymphocyte transformation. Archives of Virology. 66(4). 321–327. 28 indexed citations

12.

Weiss, Karen, et al.. (1979). Evaluation of an employee health service as a setting for a rubella screening and immunization program.. American Journal of Public Health. 69(3). 281–283. 13 indexed citations

13.

Buimovici‐Klein, Elena & L. Z. Cooper. (1979). Immunosuppression and isolation of rubella virus from human lymphocytes after vaccination with two rubella vaccines. Infection and Immunity. 25(1). 352–356. 23 indexed citations

14.

Wolinsky, Jerry S., Peter C. Dau, Elena Buimovici‐Klein, et al.. (1979). Progressive rubella panencephalitis: immunovirological studies and results of isoprinosine therapy.. PubMed. 35(3). 397–404. 18 indexed citations

15.

Weiss, Karen E., et al.. (1977). Interferon Production in Lymphocyte Cultures after Rubella Infection in Humans. The Journal of Infectious Diseases. 135(3). 380–385. 17 indexed citations

16.

Buimovici‐Klein, Elena, Timo Vesikari, Carmela Santangelo, & L. Z. Cooper. (1976). Study of the lymphocytein vitro response to rubella antigen and phytohemagglutinin by a whole blood method. Archives of Virology. 52(4). 323–331. 15 indexed citations

17.

Vesikari, Timo, G Kanra, Elena Buimovici‐Klein, & L. Z. Cooper. (1975). Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.. PubMed. 19(1). 33–43. 11 indexed citations

18.

Cooper, L. Z. & S Krugman. (1967). Clinical Manifestations of Postnatal and Congenital Rubella. Archives of Ophthalmology. 77(4). 434–439. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact